Tag: tech transfer

Managing Process Variability During Development Studies to Mitigate Regulatory Risks Process variability beyond acceptable limits during development studies can trigger significant regulatory scrutiny. This situation poses substantial risks not only…

Strategies for Addressing Poorly Justified Design Space During Pilot Scale in Pharma In pharmaceutical manufacturing and process development, the justification of design space during pilot scale operations is a critical…

Navigating Risks of Poorly Justified Design Space During Validation Planning In the landscape of pharmaceutical manufacturing, the justification of design space during validation planning is critical. A poorly defined design…

Essential Playbook for Addressing Inadequate Control Strategies During Validation Planning In the fast-paced environment of pharmaceutical manufacturing, inadequate control strategies during validation planning can lead to significant regulatory hurdles, production…

Managing Yield Loss During Optimization in Development Studies: A Practical Playbook In pharmaceutical manufacturing, particularly during the early phases of formulation and process development, yield loss can significantly impact timelines,…

Strategies to Address Poor Justification of Design Space in Development Studies Ensuring that the design space is properly justified during the formulation and process development stages is essential for regulatory…

Managing Exceeding Limits of Process Variability During Regulatory Submission In today’s pharmaceutical landscape, ensuring compliance with regulatory expectations is paramount, particularly during critical stages of drug development. When process variability…

Framework for Improving Process Robustness Amidst Inadequate Control During Validation Planning In pharmaceutical manufacturing, a control strategy that is inadequate during validation planning can jeopardize product quality and compliance, leading…

Mitigating Risks of Poorly Justified Design Space During Pilot Scale Operations The pharmaceutical landscape is fraught with challenges, particularly during the pilot scale phase. One significant issue is the poorly…

Addressing Undefined CPPs During Validation Planning: An Actionable Playbook In the pharmaceutical manufacturing landscape, the identification and definition of Critical Process Parameters (CPPs) during validation planning is pivotal for ensuring…